Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Setomimycin

Copy Product Info
😃Good
Catalog No. T26189Cas No. 69431-87-4
Alias Antibiotic A 39183B, AM-2947, AM2947, AM 2947

Setomimycin is a potent antibiotic compound that inhibits the SARS-CoV-2 main protease (Mpro) with an IC50 value of 12.02 μM, and also exhibits anti-inflammatory, antioxidant, antiproliferative, and antitumor activities, enabling multidisciplinary research spanning antiviral drug discovery, inflammation biology, and cancer pharmacology.

Setomimycin

Setomimycin

Copy Product Info
😃Good
Catalog No. T26189Alias Antibiotic A 39183B, AM-2947, AM2947, AM 2947Cas No. 69431-87-4
Setomimycin is a potent antibiotic compound that inhibits the SARS-CoV-2 main protease (Mpro) with an IC50 value of 12.02 μM, and also exhibits anti-inflammatory, antioxidant, antiproliferative, and antitumor activities, enabling multidisciplinary research spanning antiviral drug discovery, inflammation biology, and cancer pharmacology.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$19835 days35 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:Brown
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Setomimycin is a potent antibiotic compound that inhibits the SARS-CoV-2 main protease (Mpro) with an IC50 value of 12.02 μM, and also exhibits anti-inflammatory, antioxidant, antiproliferative, and antitumor activities, enabling multidisciplinary research spanning antiviral drug discovery, inflammation biology, and cancer pharmacology.
Targets&IC50
SARS-CoV-2 Mpro:12.02 μM
In vitro
In enzymatic assays, Setomimycin inhibited SARS-CoV-2 Mpro with an IC50 of 12.02 μM. In cellular models, it inhibited NO and cytokine release in LPS-stimulated macrophages (0.01-1 μM), showed antibacterial activity against Gram-positive bacteria (MIC 4-16 μg/mL), and inhibited cancer cell proliferation (IC50 4.57-48 μM) by modulating p-MEK/p-ERK/Bcl-2/Par-4 levels [1].
In vivo
In a 4T1 mouse breast cancer model using BALB/c mice, intraperitoneal (i.p.) administration of Setomimycin (20 mg/kg, every other day) for two weeks reduced primary tumor growth. The treatment resulted in a 76% reduction in tumor weight and a 90.5% reduction in tumor volume compared to the control group [2].
SynonymsAntibiotic A 39183B, AM-2947, AM2947, AM 2947
Chemical Properties
Molecular Weight580.59
FormulaC34H28O9
Cas No.69431-87-4
SmilesO=C1C=C(C)C(C(=O)C)C2=C1C(O)=C3C(O)=CC=CC3=C2C=4C=5C=CC=C(O)C5C(O)=C6C(=O)CC(O)(C)C(C(=O)C)C64
Relative Density.1.31g/cm3
Storage & Solubility Information
Storagestore at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Setomimycin | purchase Setomimycin | Setomimycin cost | order Setomimycin | Setomimycin chemical structure | Setomimycin in vivo | Setomimycin in vitro | Setomimycin formula | Setomimycin molecular weight